Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 12, Décembre 2013
Page(s) 1086 - 1088
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20132912008
Publié en ligne 20 décembre 2013
  1. Cox TM, Schofield JP. Gaucher’s disease: clinical features and natural history. Baillieres Clin Haematol 1997 ; 10 : 657–689. [CrossRef] [PubMed]
  2. Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA. Skeletal complications of Gaucher disease. Medicine 1985 ; 64 : 310–322. [CrossRef] [PubMed]
  3. Cartron JP, Elion J. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transf Clin Biol 2008 ; 15 : 39–50. [CrossRef]
  4. Nash GB, Johnson CS, Meiselman HJ. Rheologic impairment of sickle RBCs induced by repetitive cycles of deoxygenation-reoxygenation. Blood 1988 ; 72 : 539–545. [PubMed]
  5. Bratosin D, Tissier JP, Lapillonne H, et al. A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis. Cytometry B Clin Cytom 2011 ; 80 : 28–37. [CrossRef] [PubMed]
  6. Nilsson O, Hakansson G, Dreborg S, et al. Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III. Clin Genet 1982 ; 22 : 274–279. [CrossRef] [PubMed]
  7. Franco M, Collec E, Connes P, et al. Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease. Blood 2013 ; 121 : 546–555. [CrossRef] [PubMed]
  8. Gauthier E, El Nemer W, Wautier MP, et al. Role of the interaction between Lu/BCAM and the spectrin-based membrane skeleton in the increased adhesion of hereditary spherocytosis red cells to laminin. Br J Haematol 2010 ; 148 : 456–465. [CrossRef] [PubMed]
  9. Bartolucci P, Chaar V, Picot J, et al. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation. Blood 2010 ; 116 : 2152–2159. [CrossRef] [PubMed]
  10. Groener JE, Poorthuis BJ, Kuiper S, et al. Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention. Biochem Biophys Acta 2008 ; 1781 : 72–78. [CrossRef]